Value of spirometric investigations in amyotrophic lateral sclerosis
- PMID: 6862845
- DOI: 10.1007/BF02043436
Value of spirometric investigations in amyotrophic lateral sclerosis
Abstract
The respiratory function has been studied in 37 patients with ALS. 15 of them (5 till death) were followed with serial spirometric tests. The data, as a whole, show a diminution of vital capacity, a diminution of forced expiratory volume per second, an increase of the residual volume and of the Motley index; blood gas analysis showed no significant alterations apart from slight hypoxemia. Patients with bulbar ALS presented marked abnormalities of the spirometric and blood gas analysis parameters. In the cases followed with serial spirometric tests VC, Motley index and FEV1 gradually deteriorated as the disease advanced. In the deceased patients a sudden and serious aggravation of these values occurred. This was especially true for FEV1 and Motley index during the 3 months preceding death. The variations in residual volume were less indicative. Finally, the influence of smoking and of pulmonary and bronchial pathology, present or past, was not significant.
Similar articles
-
Spirometry in amyotrophic lateral sclerosis.Arch Neurol. 1979 Feb;36(2):74-80. doi: 10.1001/archneur.1979.00500380044004. Arch Neurol. 1979. PMID: 420626
-
Pulmonary function in patients with amyotrophic lateral sclerosis at disease onset.Monaldi Arch Chest Dis. 2012 Sep-Dec;77(3-4):129-33. doi: 10.4081/monaldi.2012.146. Monaldi Arch Chest Dis. 2012. PMID: 23461249
-
Respiratory function in amyotrophic lateral sclerosis.Neurol Sci. 2003 Nov;24(4):288-9. doi: 10.1007/s10072-003-0159-2. Neurol Sci. 2003. PMID: 14658052
-
Fixed ratio or lower limit of normal for the FEV1 /VC ratio: relation to symptoms and extended lung function tests.Clin Physiol Funct Imaging. 2017 May;37(3):263-269. doi: 10.1111/cpf.12294. Epub 2015 Oct 6. Clin Physiol Funct Imaging. 2017. PMID: 26443700
-
[Evaluation of ventilatory functions in amyotrophic lateral sclerosis].Rev Neurol (Paris). 2006 Jun;162 Spec No 2:4S195-4S199. Rev Neurol (Paris). 2006. PMID: 17128110 French.
Cited by
-
Tracking a Fast-Moving Disease: Longitudinal Markers, Monitoring, and Clinical Trial Endpoints in ALS.Front Neurol. 2019 Mar 19;10:229. doi: 10.3389/fneur.2019.00229. eCollection 2019. Front Neurol. 2019. PMID: 30941088 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Medical
Miscellaneous